Rationale: SM22 (or transgelin), an actin-binding protein abundant in vascular smooth muscle cells (VSMCs), is downregulated in atherosclerosis, aneurysm and various cancers. Abolishing SM22 in apolipoprotein E knockout mice accelerates atherogenesis. However, it is unclear whether SM22 disruption independently promotes arterial inflammation. Objective: To investigate whether SM22 disruption directly promotes inflammation on arterial injury and to characterize the underlying mechanisms. Methods and Results: Using carotid denudation as an artery injury model, we showed that Sm22 knockout (Sm22 ؊/؊ ) mice developed enhanced inflammatory responses with higher induction of proinflammatory genes, including Vcam1, Icam1, Cx3cl1, Ccl2, and Ptgs2. Higher expression of these genes was confirmed in primary Sm22 ؊/؊ VSMCs and in PAC1 cells after Sm22 knockdown, whereas SM22 recapitulation in primary Sm22 ؊/؊ VSMCs decreased their expression. NFKB2 was prominently activated in both injured carotids of Sm22 ؊/؊ mice and in PAC1 cells after Sm22 knockdown and may mediate upregulation of these proinflammatory genes. As a NF-B activator, reactive oxygen species (ROS) increased in primary Sm22 ؊/؊ VSMCs and in PAC1 cells after Sm22 knockdown. ROS scavengers blocked NF-B activation and induction of proinflammatory genes. Furthermore, Sm22 knockdown increased Sod2 expression and activated p47phox, reflecting contributions of mitochondria and NADPH oxidase to the augmented ROS production; this may result from actin and microtubule cytoskeletal remodeling.
Conclusions: Our findings show that SM22 downregulation can induce proinflammatory VSMCs through activation of ROS-mediated NF-B pathways. This study provides initial evidence linking VSMC cytoskeleton remodeling with arterial inflammation. (Circ Res. 2010;106:1351-1362.)Key Words: VSMC Ⅲ SM22 Ⅲ inflammation Ⅲ NF-B Ⅲ ROS S M22, also known as SM22␣ or transgelin, is a 22 kDa protein abundant in the smooth muscle cells (SMCs) of vertebrates. 1 It belongs to the calponin family because it contains an N-terminal calponin homology domain and a C-terminal calponin-like domain. 2 The basic molecular function of SM22 is to bind actin and facilitate the formation of cytoskeletal structures such as stress fibers. 2 SM22 dysregulation is observed in a variety of human diseases. For instance, expression of SM22 is decreased in several types of cancer. 3 Expression of SM22 is also downregulated in atherosclerotic arteries 4,5 and abdominal aortic aneurysms. 6 These findings suggest a correlation between decreased SM22 expression and arterial diseases. However, it is unclear whether the SM22 downregulation promotes the pathogenesis of arterial diseases or whether it is simply a passive outcome.SM22 has been widely used as a SMC marker during embryogenesis and in adult. 7 Sm22 knockout (Sm22 Ϫ/Ϫ ) mice are viable and fertile with uncompromised vasculature development. 8 -10 This suggests that SM22 may be either functionally redundant or compensated during vasculature development. However, th...